Personalised oncogenomics: Is a precision approach necessary for every cancer or is there a therapy-driven bottleneck?

Date 29 September 2019
Event ESMO 2019 Congress
Session Molecular tumour board: Where do we stand? What’s next?
Topics Ovarian Cancer
Endometrial Cancer
Cancer Biology
Pathology/Molecular Biology
Rare Cancers
Presenter David Huntsman
Authors D. Huntsman
  • Department Pathology And Laboratory Medicine, British Columbia Cancer Agency, V5Z 4E6 - Vancouver/CA